TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Rechon Life Science AB
Closing information (x1000 DKK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 259,442 | 222,248 | 227,513 |
Financial expenses | 866 | 765 | 777 |
Earnings before taxes | 40,264 | 21,277 | 20,037 |
EBITDA | 52,013 | 31,452 | 27,843 |
Total assets | 218,478 | 206,264 | 161,237 |
Current assets | 112,442 | 97,732 | 101,956 |
Current liabilities | 53,338 | 38,673 | 44,137 |
Equity capital | 113,378 | 95,114 | 87,038 |
- share capital | 18,404 | 20,026 | 20,412 |
Employees (average) | 212 | 184 | 175 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 51.9% | 46.1% | 54.0% |
Turnover per employee | 1,224 | 1,208 | 1,300 |
Profit as a percentage of turnover | 15.5% | 9.6% | 8.8% |
Return on assets (ROA) | 18.8% | 10.7% | 12.9% |
Current ratio | 210.8% | 252.7% | 231.0% |
Return on equity (ROE) | 35.5% | 22.4% | 23.0% |
Change turnover | 55,196 | -959 | -6,624 |
Change turnover % | 27% | 0% | -3% |
Chg. No. of employees | 28 | 9 | 4 |
Chg. No. of employees % | 15% | 5% | 2% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.